Finepoint Capital LP Diversified Active

Location: Boston, MA

CIK: 0001608126 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 12, 2023

Total Value: $262M (100.0% shares, 0.0% debt)

Holdings (38)

TVTX TRAVERE THERAPEUTICS INC 7.5%

Value $19.68M Shares 875,221 Est. Cost $25.45 Unrealized -16.5%

APLS APELLIS PHARMACEUTICALS INC 7.1%

Value $18.71M Shares 283,690 Est. Cost $47.12 Unrealized +22.4%

— IVERIC BIO INC 6.7%

Value $17.61M Shares 723,600 Est. Cost $9.95 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 6.6%

Value $17.25M Shares 916,353 Est. Cost $17.65 Unrealized +7.9%

GLPG GALAPAGOS NV 6.6%

Value $17.18M Shares 444,659 Est. Cost $49.87 Unrealized —

SRPT SAREPTA THERAPEUTICS INC 6.5%

Value $16.92M Shares 122,757 Est. Cost $115.88 Unrealized +11.9%

ASND ASCENDIS PHARMA A/S 6.4%

Value $16.73M Shares 156,072 Est. Cost $96.96 Unrealized —

— SAGE THERAPEUTICS INC 6.2%

Value $16.32M Shares 388,865 Est. Cost $32.48 Unrealized —

FOLD AMICUS THERAPEUTICS INC 6.2%

Value $16.19M Shares 1,460,175 Est. Cost $8.32 Unrealized +48.1%

PRTA PROTHENA CORP PLC 6.1%

Value $16.07M Shares 331,600 Est. Cost $31.42 Unrealized +68.1%

— SPRINGWORKS THERAPEUTICS INC 6.0%

Value $15.81M Shares 614,231 Est. Cost $27.22 Unrealized —

CYTK CYTOKINETICS INC 5.6%

Value $14.56M Shares 413,793 Est. Cost $40.42 Unrealized +0.9%

CRNX CRINETICS PHARMACEUTICALS IN 5.3%

Value $13.95M Shares 868,427 Est. Cost $17.67 Unrealized +4.7%

RLAY RELAY THERAPEUTICS INC 5.3%

Value $13.94M Shares 846,270 Est. Cost $18.95 Unrealized -5.4%

ARVN ARVINAS INC 5.1%

Value $13.45M Shares 492,300 Est. Cost $45.99 Unrealized -31.3%

— CEREVEL THERAPEUTICS HLDNG I 5.0%

Value $13.16M Shares 539,445 Est. Cost $28.10 Unrealized —

SLDB SOLID BIOSCIENCES INC 0.9%

Value $2.317M Shares 488,857 Est. Cost $6.25 Unrealized -3.9%

— ARES ACQUISITION CORP 0.2%

Value $444K Shares 504,706 Est. Cost $0.85 Unrealized —

— HOME PLATE ACQUISITION CORP 0.1%

Value $219K Shares 690,000 Est. Cost $0.60 Unrealized —

— BRIDGETOWN HOLDINGS LTD 0.1%

Value $134K Shares 895,000 Est. Cost $1.24 Unrealized —

— ROSS ACQUISITION CORP II 0.0%

Value $115K Shares 439,666 Est. Cost $0.89 Unrealized —

— CONYERS PARK III ACQUISITION CORP 0.0%

Value $114K Shares 571,666 Est. Cost $1.04 Unrealized —

— CHURCHILL CAPITAL CORP V 0.0%

Value $114K Shares 612,000 Est. Cost $1.30 Unrealized —

— MARBLEGATE ACQUISITION CORP 0.0%

Value $110K Shares 735,000 Est. Cost $0.50 Unrealized —

LSBWF YS BIOPHARMA CO LTD 0.0%

Value $76,293 Shares 489,999 Est. Cost $0.16 Unrealized —

— CHURCHILL CAPITAL CORP VII 0.0%

Value $67,130 Shares 548,000 Est. Cost $0.92 Unrealized —

— AFTERNEXT HEALTHTECH ACQUISITION CORP 0.0%

Value $61,087 Shares 366,666 Est. Cost $0.70 Unrealized —

— ZIMMER ENERGY TRANSITION ACQUISITION CORP 0.0%

Value $60,118 Shares 358,270 Est. Cost $1.34 Unrealized —

— JAWS HURRICANE ACQUISITION CORP 0.0%

Value $60,062 Shares 387,249 Est. Cost $1.15 Unrealized —

IVCPW SWIFTMERGE ACQUISITION CORP 0.0%

Value $59,878 Shares 490,000 Est. Cost $0.21 Unrealized —

CDAWF COMPASS DIGITAL ACQUISITION CORP 0.0%

Value $59,834 Shares 459,906 Est. Cost $0.76 Unrealized —

— CHURCHILL CAPITAL CORP VI 0.0%

Value $59,400 Shares 540,000 Est. Cost $1.20 Unrealized —

— CORSAIR PARTNERING CORP 0.0%

Value $53,580 Shares 334,666 Est. Cost $0.76 Unrealized —

— SENIOR CONNECT ACQUISITION COR 0.0%

Value $51,308 Shares 1,014,000 Est. Cost $0.71 Unrealized —

CNDAW CONCORD ACQUISITION CORP II 0.0%

Value $28,583 Shares 408,333 Est. Cost $0.95 Unrealized —

CLDWW FIRST LIGHT ACQUISITION GROUP INC 0.0%

Value $26,863 Shares 655,200 Est. Cost $0.50 Unrealized —

— BILANDER ACQUISITION CORP 0.0%

Value $23,887 Shares 183,749 Est. Cost $1.10 Unrealized —

— SKYDECK ACQUISITION CORP 0.0%

Value $18,088 Shares 361,756 Est. Cost $0.75 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
TVTX	TRAVERE THERAPEUTICS INC	875,221	$19.68M	7.5%	$25.45	-16.5%	COM	89422G107
APLS	APELLIS PHARMACEUTICALS INC	283,690	$18.71M	7.1%	$47.12	+22.4%	COM	03753U106
—	IVERIC BIO INC	723,600	$17.61M	6.7%	$9.95	—	COM	46583P102
ACAD	ACADIA PHARMACEUTICALS INC	916,353	$17.25M	6.6%	$17.65	+7.9%	COM	004225108
GLPG	GALAPAGOS NV	444,659	$17.18M	6.6%	$49.87	—	SPON ADR	36315X101
SRPT	SAREPTA THERAPEUTICS INC	122,757	$16.92M	6.5%	$115.88	+11.9%	COM	803607100
ASND	ASCENDIS PHARMA A/S	156,072	$16.73M	6.4%	$96.96	—	SPONSORED ADR	04351P101
—	SAGE THERAPEUTICS INC	388,865	$16.32M	6.2%	$32.48	—	COM	78667J108
FOLD	AMICUS THERAPEUTICS INC	1,460,175	$16.19M	6.2%	$8.32	+48.1%	COM	03152W109
PRTA	PROTHENA CORP PLC	331,600	$16.07M	6.1%	$31.42	+68.1%	SHS	G72800108
—	SPRINGWORKS THERAPEUTICS INC	614,231	$15.81M	6.0%	$27.22	—	COM	85205L107
CYTK	CYTOKINETICS INC	413,793	$14.56M	5.6%	$40.42	+0.9%	COM NEW	23282W605
CRNX	CRINETICS PHARMACEUTICALS IN	868,427	$13.95M	5.3%	$17.67	+4.7%	COM	22663K107
RLAY	RELAY THERAPEUTICS INC	846,270	$13.94M	5.3%	$18.95	-5.4%	COM	75943R102
ARVN	ARVINAS INC	492,300	$13.45M	5.1%	$45.99	-31.3%	COM	04335A105
—	CEREVEL THERAPEUTICS HLDNG I	539,445	$13.16M	5.0%	$28.10	—	COM	15678U128
SLDB	SOLID BIOSCIENCES INC	488,857	$2.317M	0.9%	$6.25	-3.9%	COM NEW	83422E204
—	ARES ACQUISITION CORP	504,706	$444K	0.2%	$0.85	—	*W EXP 02/02/202	G33032122
—	HOME PLATE ACQUISITION CORP	690,000	$219K	0.1%	$0.60	—	*W EXP 09/30/202	43734R111
—	BRIDGETOWN HOLDINGS LTD	895,000	$134K	0.1%	$1.24	—	*W EXP 09/30/202	G1355U121
—	ROSS ACQUISITION CORP II	439,666	$115K	0.0%	$0.89	—	*W EXP 02/01/202	G7641C114
—	CONYERS PARK III ACQUISITION CORP	571,666	$114K	0.0%	$1.04	—	*W EXP 08/12/202	21289P110
—	CHURCHILL CAPITAL CORP V	612,000	$114K	0.0%	$1.30	—	*W EXP 10/29/202	17144T115
—	MARBLEGATE ACQUISITION CORP	735,000	$110K	0.0%	$0.50	—	*W EXP 08/31/202	56608A113
LSBWF	YS BIOPHARMA CO LTD	489,999	$76,293	0.0%	$0.16	—	*W EXP 03/15/202	G9845F117
—	CHURCHILL CAPITAL CORP VII	548,000	$67,130	0.0%	$0.92	—	*W EXP 02/29/202	17144M110
—	AFTERNEXT HEALTHTECH ACQUISITION CORP	366,666	$61,087	0.0%	$0.70	—	*W EXP 99/99/999	G01109126
—	ZIMMER ENERGY TRANSITION ACQUISITION CORP	358,270	$60,118	0.0%	$1.34	—	*W EXP 06/16/202	989570114
—	JAWS HURRICANE ACQUISITION CORP	387,249	$60,062	0.0%	$1.15	—	*W EXP 03/26/202	47201B111
IVCPW	SWIFTMERGE ACQUISITION CORP	490,000	$59,878	0.0%	$0.21	—	*W EXP 12/13/202	G63836111
CDAWF	COMPASS DIGITAL ACQUISITION CORP	459,906	$59,834	0.0%	$0.76	—	*W EXP 09/29/202	G2476C123
—	CHURCHILL CAPITAL CORP VI	540,000	$59,400	0.0%	$1.20	—	*W EXP 02/17/202	17143W119
—	CORSAIR PARTNERING CORP	334,666	$53,580	0.0%	$0.76	—	*W EXP 07/06/202	G2540H116
—	SENIOR CONNECT ACQUISITION COR	1,014,000	$51,308	0.0%	$0.71	—	*W EXP 12/31/202	81723H116
CNDAW	CONCORD ACQUISITION CORP II	408,333	$28,583	0.0%	$0.95	—	*W EXP 99/99/999	20607U116
CLDWW	FIRST LIGHT ACQUISITION GROUP INC	655,200	$26,863	0.0%	$0.50	—	*W EXP 03/14/202	320703119
—	BILANDER ACQUISITION CORP	183,749	$23,887	0.0%	$1.10	—	*W EXP 05/19/202	09001T114
—	SKYDECK ACQUISITION CORP	361,756	$18,088	0.0%	$0.75	—	*W EXP 05/13/202	G82220115